| NTEC - Intec Pharma Ltd (Healthcare: Biotechnology) | Projected Earnings Date: 0000-02-29 (Delayed quote data ) |
|
|
|||||||||||||||||
|
|
|
| Company Profile | |
| Intec Pharma Ltd is a clinical-stage biopharmaceutical company based in Israel. It is a development-stage biopharmaceutical company. The company has focused its efforts on research and development and clinical trials. The company develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing efficient gastric retention. Accordion Pill Carbidopa/Levodopa or AP-CDLD is being developed by the company for the indication of treatment of Parkinson's disease. | |
| Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. |